Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1-Associated Genes in Finnish Patients with Uveal Melanoma.
Repo PE, Jakkula E, Hiltunen J, Putkuri H, Staskiewicz-Tuikkanen A, Järvinen RS, Täll M, Raivio V, Al-Jamal RT, Kivelä TT, Turunen JA. Repo PE, et al. Among authors: hiltunen j. Pigment Cell Melanoma Res. 2025 Jan;38(1):e13198. doi: 10.1111/pcmr.13198. Epub 2024 Sep 30. Pigment Cell Melanoma Res. 2025. PMID: 39344744 Free PMC article.
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic Window.
Satomaa T, Pynnönen H, Aitio O, Hiltunen JO, Pitkänen V, Lähteenmäki T, Kotiranta T, Heiskanen A, Hänninen AL, Niemelä R, Helin J, Kuusanmäki H, Vänttinen I, Rathod R, Nieminen AI, Yatkin E, Heckman CA, Kontro M, Saarinen J. Satomaa T, et al. Among authors: hiltunen jo. Mol Cancer Ther. 2024 Aug 1;23(8):1073-1083. doi: 10.1158/1535-7163.MCT-23-0720. Mol Cancer Ther. 2024. PMID: 38561023
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.
Goldberg SD, Satomaa T, Aina O, Aitio O, Burke K, Dudkin V, Geist B, Irrechukwu O, Hänninen AL, Heiskanen A, Helin J, Hiltunen JO, Kinyamu-Akunda J, Klein DM, Kohli N, Kotiranta T, Lähteenmäki T, Niemelä R, Pitkänen V, Pynnönen H, Rittase W, Wiley K, Zhou J, Saarinen J. Goldberg SD, et al. Among authors: hiltunen jo. Mol Cancer Ther. 2024 Nov 4;23(11):1530-1543. doi: 10.1158/1535-7163.MCT-23-0591. Mol Cancer Ther. 2024. PMID: 38324296
Enrichment of sweat-derived extracellular vesicles of human and bacterial origin for biomarker identification.
Zhyvolozhnyi A, Samoylenko A, Bart G, Kaisanlahti A, Hekkala J, Makieieva O, Pratiwi F, Miinalainen I, Kaakinen M, Bergman U, Singh P, Nurmi T, Khosrowbadi E, Abdelrady E, Kellokumpu S, Kosamo S, Reunanen J, Röning J, Hiltunen J, Vainio SJ. Zhyvolozhnyi A, et al. Among authors: hiltunen j. Nanotheranostics. 2024 Jan 1;8(1):48-63. doi: 10.7150/ntno.87822. eCollection 2024. Nanotheranostics. 2024. PMID: 38164498 Free PMC article.
Analysis of glaucoma genes in Finnish patients with juvenile open-angle glaucoma.
Liuska PJ, Tadji A, Repo P, Hiltunen J, Backlund M, Järvinen RS, Ojanen E, Majander A, Kivelä TT, Harju M, Turunen JA. Liuska PJ, et al. Among authors: hiltunen j. Acta Ophthalmol. 2023 Nov;101(7):797-806. doi: 10.1111/aos.15670. Epub 2023 Apr 9. Acta Ophthalmol. 2023. PMID: 37032519 Free article.
322 results